4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-009270
EVP, CHIEF FINANCIAL OFFICER sold 5,434 shares at $17.90 ($97,269)
- EVP, CHIEF FINANCIAL OFFICER acquired 10,550 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-03-25 | Grant or award | +10,550 | 31,617 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-03-27 | Sale | −5,434 | $17.90 | $97,269 | 26,183 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-03-25 | Grant or award · Stock Options (Right to Buy) | +80,564 | 80,564 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-03-25 | Grant or award · Restricted Stock Units | +24,714 | 24,714 | D | ||
| Open-market sales · 5,434 sh · avg $17.90 · $97,269 | |||||||
Loading xslF345X05/form4-03272024_110354.xml…